How Co‑Packer COA Columns Drive Cannabinoid Inflation Recalls

Introduction

Cannabinoid inflation recalls happen when a product’s label states higher THC or CBD levels than what testing shows. The root cause often traces back to how a co‑packer reads and transfers data from a laboratory certificate of analysis (COA). This post explains the mechanics of COA columns, where errors creep in, and what distributors can do to avoid triggering an "Inaccurate Labeling (Cannabinoid inflation)" finding.

What a COA Column Looks Like

A testing lab’s COA typically presents potency results in a table. Common column headers include:

• Analyte (e.g., Delta‑9 THC, THCA, CBD, CBDA)
• Result (% or mg/g)
• Unit
• LOQ (limit of quantitation)
• Method

Each row corresponds to one analyte. The result column is the numeric value that will become the label claim after any required conversions (e.g., THCA to Delta‑9 THC).

How Co‑Packers Use COA Data

Co‑packers receive the COA from the contracted lab. They then extract the numbers to create or update product labels, packaging artwork, and Metrc transfer notes. The process may involve:

• Copy‑pasting cells from a PDF or spreadsheet into a label template
• Applying conversion formulas (e.g., total THC = Delta‑9 THC + (THCA × 0.877))
• Rounding to the required decimal places

If the co‑packer misaligns rows, reads the wrong column, or applies a formula to the wrong analyte, the resulting label claim can be higher than the true potency.

Common Column‑Mix‑Up Errors

1. Wrong analyte row – The co‑packer copies the THCA result into the Delta‑9 THC field, then adds the conversion factor, effectively double‑counting the acid form.
2. Unit confusion – Mistaking mg/g for % (or vice versa) leads to a ten‑fold inflation.
3. Incorrect formula application – Using the THCA conversion factor on a CBD row, or applying a moisture‑correction factor where it does not belong.
4. Column header shift – When a lab adds a new column (e.g., for a minor cannabinoid), the co‑packer’s template still expects the old layout, shifting all data one column to the left or right.
5. Rounding direction – Rounding up instead of to the nearest permitted increment can push a label claim over the threshold that triggers a recall.

Each of these mistakes produces a label that overstates cannabinoid content. When a regulator samples the product and finds the actual potency lower than the label, the recall reason is recorded as "Inaccurate Labeling (Cannabinoid inflation)".

Regulator Language on Misbranding

California’s recall notices use specific verbatim phrases. When potency is overstated, the notice will state:

• "Inaccurate Labeling (Cannabinoid inflation)"
• "Misbranded"

These phrases appear in the recall summary posted at https://recalls.cannabis.ca.gov. The regulator does not disclose the internal workflow that caused the error; the public record only shows the outcome and the standardized reason.

Preventing Column Errors

Distributors can reduce risk by building checks into the co‑packer workflow:

• Template lock‑down – Use a label‑generation template that pulls data by column header name, not by cell position. This prevents shift errors when labs add or remove columns.
• Automated validation – After the co‑packer enters the COA numbers, run a script that compares the entered values to the original COA (e.g., via a hash of the PDF text) and flags any mismatch.
• Cross‑check conversion – Require a second person to verify that the total THC calculation used the correct analyte and factor.
• Unit audit – Include a step that confirms the unit of each result matches the unit expected by the label specification.
• Spot‑sample testing – Before final packaging, send a representative sample to an independent lab for potency verification. If the label claim exceeds the verified result by more than the allowed variance, halt the run.

These controls do not guarantee perfection, but they address the most frequent column‑related mistakes that lead to inflation recalls.

Using Recall Trend Data

Tracking how often "Inaccurate Labeling (Cannabinoid inflation)" appears can help prioritize interventions. The recall trend page at https://phenominal.io/recall-trend shows monthly counts of recall reasons, including labeling issues. While the page does not name individual co‑packers, it reveals whether labeling problems are rising, stable, or falling across the state. Distributors can use that information to decide when to tighten internal audits or update co‑packer agreements.

Conclusion

Co‑packer COA columns are a routine part of the labeling pipeline, but they are also a frequent source of cannabinoid inflation errors. Misreading a row, confusing units, or applying a conversion to the wrong analyte creates a label that overstates potency. When state sampling catches the discrepancy, the recall notice cites "Inaccurate Labeling (Cannabinoid inflation)" and "Misbranded". By building template‑driven, header‑based data pulls, adding automated validation steps, and verifying label claims with spot‑sample testing, distributors can reduce the chance that a column mix‑up leads to a recall. Monitoring recall trends through publicly available data helps teams see whether their controls are having the desired effect.